Showing results (571-580 of 4,042) with videos related to
Sort By:
Pageof 405
Pharmacoepidemiology and Drug Safety|March 30, 2021
Risk of antibiotic treatment failure in premenopausal women with uncomplicated urinary tract infectionAnne M Butler, Michael J Durkin, Matthew R Keller, et al.Pharmacoepidemiology and Drug Safety|August 4, 2020
Pharmacoepidemiology of testosterone: Impact of reimbursement policy on curbing off-label prescribingDavid J HandelsmanPharmacoepidemiology and Drug Safety|August 21, 2020
Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United StatesPardiss Kaviani, Suzanne N Landi, Aaron McKethan, et al.Pharmacoepidemiology and Drug Safety|April 3, 2015
Reduced prevalence of chronic tubal inflammation in tubal pregnancies after levonorgestrel emergency contraception failureCheng Li, Chun-Xia Meng, Lu-Lu Sun, et al.Pharmacoepidemiology and Drug Safety|April 9, 2015
High perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medicationKate Faasse, Andrew Grey, Rob Horne, et al.Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.Pharmacoepidemiology and Drug Safety|April 9, 2021
A systematic review of how missing data are handled and reported in multi-database pharmacoepidemiologic studiesNicholas B Hunt, Helga Gardarsdottir, Marloes T Bazelier, et al.Pharmacoepidemiology and Drug Safety|April 11, 2021
Trends in strong opioid prescribing in Ireland: A repeated cross-sectional analysis of a national pharmacy claims database between 2010 and 2019Brid A Norris, Amelia Smith, Stephen Doran, et al.Pharmacoepidemiology and Drug Safety|April 11, 2021
Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world studySu-Yeon Yu, Dan Mckavanagh, Ian McPherson, et al.Pharmacoepidemiology and Drug Safety|April 17, 2021
Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistanceJean Marie Vianney Habarugira, Albert FiguerasPageof 405